The presence of MYD88L265P in IgM-MGUS suggests that it is an early oncogenic factor, but most IgM-MGUS patients never progress to WM or other lymphoproliferative disorders, so this mutation cannot be considered a unique pathogenic factor in WM [46,47]. The gene discussed is CD40LG; the disease is lymphoproliferative syndrome.